169.41 USD
-1.75 (-1.02%)
169.41 USD
0 (0%)
ChartMill assigns a Buy % Consensus number of 85% to JAZZ. The Buy consensus is the weighted average rating of the current analysts ratings.
- Analysts have set a mean price target forecast of 220.93. This target is 30.41% above the current price.
- JAZZ was analyzed by 23 analysts. The buy percentage consensus is at 85. So analysts seem to be very confident about JAZZ.
- In the previous month the buy percentage consensus was at a similar level.
- JAZZ was analyzed by 23 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2026-01-12 | Needham | Maintains | Buy -> Buy |
| 2026-01-12 | Truist Securities | Maintains | Buy -> Buy |
| 2025-12-10 | Piper Sandler | Reiterate | Overweight -> Overweight |
| 2025-11-24 | UBS | Downgrade | Buy -> Neutral |
| 2025-11-18 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2025-11-18 | Baird | Maintains | Outperform -> Outperform |
| 2025-11-18 | B of A Securities | Maintains | Buy -> Buy |
| 2025-11-17 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2025-11-06 | RBC Capital | Maintains | Outperform -> Outperform |
| 2025-10-27 | JP Morgan | Maintains | Overweight -> Overweight |
| 2025-10-20 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2025-09-24 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2025-08-29 | Goldman Sachs | Maintains | Buy -> Buy |
| 2025-08-28 | Needham | Reiterate | Buy -> Buy |
| 2025-08-28 | RBC Capital | Maintains | Outperform -> Outperform |
| 2025-08-28 | Truist Securities | Maintains | Buy -> Buy |
| 2025-08-28 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2025-08-20 | Needham | Reiterate | Buy -> Buy |
| 2025-08-06 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2025-07-22 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2025-06-11 | Needham | Reiterate | Buy -> Buy |
| 2025-06-03 | Needham | Reiterate | Buy -> Buy |
| 2025-05-07 | Needham | Reiterate | Buy -> Buy |
| 2025-05-07 | RBC Capital | Maintains | Outperform -> Outperform |
| 2025-05-07 | Baird | Maintains | Outperform -> Outperform |
| 2025-05-07 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2025-05-07 | Piper Sandler | Reiterate | Overweight -> Overweight |
| 2025-04-10 | Needham | Reiterate | Buy -> Buy |
| 2025-03-10 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-03-07 | UBS | Upgrade | Neutral -> Buy |
JAZZ PHARMACEUTICALS PLC / JAZZ FAQ
What do analysts expect the price target to be for JAZZ PHARMACEUTICALS PLC (JAZZ)?
23 analysts have analysed JAZZ and the average price target is 220.93 USD. This implies a price increase of 30.41% is expected in the next year compared to the current price of 169.41.
Can you provide the consensus rating for JAZZ PHARMACEUTICALS PLC stock?
The consensus rating for JAZZ PHARMACEUTICALS PLC (JAZZ) is 85.2174 / 100 . This indicates that analysts generally have a positive outlook on the stock.
Can you provide the analyst count for JAZZ PHARMACEUTICALS PLC stock?
The number of analysts covering JAZZ PHARMACEUTICALS PLC (JAZZ) is 23.